Table 1.
Patient and clinical characteristics
Variable | Value |
---|---|
Total Number of Patients | 34 |
Age | |
Median (range) | 68 (27–84) |
Sex | |
Male | 20 (59 %) |
Female | 14 (41 %) |
KPS | |
Median (range) | 90 (60–100) |
Histology | |
Clear Cell | 48 (91 %) |
Papillary | 4 (7 %) |
Not Otherwise Specified | 1 (2 %) |
Treatment Patterns | |
Treated with SBRT | 36 (68 %) |
25 Gy/1 fx | 2 |
30 Gy/2 fx | 1 |
54 Gy/4 fx | 1 |
24–60 Gy/3 fx | 15 |
25–50 Gy/5 fx | 14 |
40 Gy/8 fx | 1 |
50 Gy/10 fx | 2 |
Treated with CF-EBRT | 17 (32 %) |
20 Gy/5 fx | 5 |
32 Gy/8 fx | 1 |
30–40 Gy/10 fx | 8 |
45 Gy/13 fx | 1 |
45 Gy/15 fx | 1 |
55 Gy/22 fx | 1 |
KPS karnofsky performance status, SBRT stereotactic body radiotherapy, CF-EBRT conventional fractionated external beam radiotherapy